donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Medical Disorders
Resources
Basic InformationLookupsLatest News
Delta Variant Convinced Many to Get Vaccinated: PollOver Half of American Children Have Detectable Lead Levels in Their BloodSmartphone Apps May Aid in Heart Attack RecoveryBetter Diet, More Exercise Equals Better Blood PressureIntermittent Fasting Can Cut Your Risk of Diabetes, Heart DiseaseMask Mandates in Schools Curb Infections, CDC Studies ShowPfizer to Ask FDA Soon for Approval of Its COVID Vaccine for Younger ChildrenYou Think You Had COVID Before: Are You Really Immune Now?Keep Your Kids Safe From COVID While Playing SportsAHA News: Women May Be More Willing Than Men to Donate OrgansDNA Sensor Can Spot When COVID Is ContagiousTrials Show COVID Vaccines Well Worth It for Cancer PatientsCDC Endorses Booster Shots for Millions of AmericansChildhood Trauma Linked With Higher Odds for Adult Neurological IllsCancer in Hispanics: Good News and BadFDA Approves Pfizer Booster Shots for Seniors, High-Risk AmericansU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationAntibodies to Early Strains of COVID May Not Fight New Variants: StudyPregnant Women Who Get COVID Vaccine Pass Antibodies to NewbornsCDC Expert Panel to Weigh In on Vaccine BoostersWhich Kids Are at Highest Risk From COVID?4 Out of 10 Adults With No Known Heart Disease Have Fatty Hearts: StudyBooster Dose of J&J COVID Vaccine Increases ImmunityPost-Stroke Rehab: There's a Sweet Spot in the TimingCommon Form of Liver Cancer on the Rise in Rural AmericaCOVID Has Killed More Americans Than the Spanish Flu Did in 1918Telemedicine Gets High Marks for Follow-Ups After SurgeryPandemic Tied to Declining Birth Rates for U.S., Much of EuropeReview of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: FauciDelta Variant Now Fueling 99% of U.S. COVID CasesLower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company SaysFDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not YoungerPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: Study
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

'Superbug' Fungus Spreads Among Vulnerable in Two U.S. Cities

HealthDay News
by Robert Preidt
Updated: Jul 23rd 2021

new article illustration

FRIDAY, July 23, 2021 (HealthDay News) -- An untreatable "superbug" fungus is spreading in a Washington, D.C., nursing home and two Dallas-area hospitals, the U.S. Centers for Disease Control and Prevention said Thursday.

There were 101 candida auris cases at the nursing home and 22 cases at the hospitals from January to April, according to the U.S. Centers for Disease Control and Prevention, which did not identify the facilities, the Associated Press reported.

Three of the patients at the nursing home and two at the hospitals had infections that were resistant to all three major classes of antifungal medications. Of those patients, both patients in Texas and one in Washington died.

Both outbreaks are ongoing and more infections have been identified since April, but the CDC didn't release those additional numbers, the AP reported.

"This is really the first time we've started seeing clustering of [drug] resistance" in which infections appear to be spreading between patients, the CDC's Dr. Meghan Lyman told the AP.

C. auris is a form of yeast that's a threat to hospital and nursing home patients with serious medical problems. It is most dangerous when it enters the bloodstream, heart or brain.

For years, health officials have sounded alarms about the drug-resistant fungus after seeing infections in which commonly used medicines had little effect. In 2019, doctors diagnosed three cases in New York that were also resistant to a class of drugs, called echinocandins, that were considered a last line of defense, the AP reported.

In those cases, there was no evidence the infections had spread from patient to patient — scientists concluded the resistance to the drugs had formed during an individual patient's treatment. But these new outbreaks could be different, the CDC's Lyman said.

More information

Visit the U.S. Centers of Disease Control and Prevention for more on candida auris.


SOURCE: Associated Press